According to a report Online First by Archives of Pediatrics & Adolescent Medicine, babies who are born to mothers with diabetes during their pregnancy and/or living in low income households, have a higher risk of subsequently developing ADHD during childhood. The authors stated: "Gestational diabetes mellitus (GDM) typically develops in the second and third trimesters and is defined as glucose intolerance with onset or first recognition during pregnancy. The prevalence of GDM has been rising for over 20 years, particularly among ethnic minorities and individuals with low socioeconomic status (SES), as have lifestyle changes that heighten risk including greater consumption of saturated fats, sugar, and processed foods, and sedentary working environments." Yoko Nomura, M.D., Ph.D, of Queens College, and team set out to determine whether there might be a connection between gestational diabetes mellitus (GDM) and low income environments, with attention deficit hyperactivity disorder (ADHD).
In the first study of its kind, researchers at Queens College and Mount Sinai School of Medicine have found that low socioeconomic status (SES) and maternal gestational diabetes together may cause a 14-fold increased risk of attention deficit hyperactivity disorder ( ADHD ) in six year olds. The data are published in the January issue of the Archives of Pediatrics and Adolescent Medicine, one of the JAMA/Archives journals. Led by Jeffrey M. Halperin, PhD, Distinguished Professor of Psychology at Queens College and Professorial Lecturer in Psychiatry at Mount Sinai, and Yoko Nomura, PhD, Assistant Professor of Psychology at Queens College and Assistant Clinical Professor of Psychiatry at Mount Sinai, the research team evaluated 212 children at age three or four and again at age six.
Adderall is a stimulant used to treat ADHD, but it's also a controlled substance due to the addictive qualities of the drug. The DEA (Drug Enforcement Agency) monitors and controls how much of the base ingredients to manufacture the drug can be distributed to pharmaceutical companies. This bottle-neck means that manufacturers are left without the active ingredients they need to make the drug for commercial and medical use. Ironically, the system is specifically designed to prevent stock-piles of the controlled ingredients and the drug itself, that could be subverted for illicit use. DEA assesses how much legitimate usage is likely for the year, and accordingly releases the mixed amphetamine salts to the manufacturers. However, drug makers are facing soaring demand and are finding themselves at loggerheads with the DEA.
Young and middle-aged adults who are prescribed ADHD (attention deficit/hyperactivity disorder) drugs do not have a higher chance of developing serious cardiovascular events, such as sudden cardiac death, heart attack or stroke, researchers from Kaiser Permanente Northern California, Oakland, reported in JAMA (Journal of the American Medical Association). The authors explained that there had been concerns regarding the cardiovascular consequences of taking ADHD medications. This is because they can raise the patient's heart rate and blood pressure. However, this latest study, involving 150, 359 adults with ADHD, found no higher risk of having a cardiovascular event in people taking ADHD medications compared to those who don't. All the adults were young to middle-aged. The findings of this study are being published ahead of schedule because of their public health importance.
In a new study to appear in Neuron, scientists at the RIKEN Brain Science Institute (BSI) have uncovered mechanisms that help our brain to focus by efficiently routing only relevant information to perceptual brain regions. The results provide valuable insights on how our brains achieve such focus and on how this focus can be disrupted, suggesting new ways of presenting information that augment the brain's natural focal capabilities. Focus on what I am about to tell you! Our complex modern world is filled with so many distractions - flashing images on a television screen, blinking lights, blaring horns - that our ability to concentrate on one thing at a time is of critical importance. How does our brain achieve this ability to focus attention? The answer is believed to lie in two distinct processes, referred to as "sensitivity enhancement" and "efficient selection".